Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 233

1.

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE, Mehrotra R, Stevens PE, Wang AY, Cheung M, Wheeler DC, Winkelmayer WC, Pollock CA; Conference Participants.

Kidney Int. 2019 Jul;96(1):37-47. doi: 10.1016/j.kint.2019.01.017. Epub 2019 Apr 13.

PMID:
30987837
2.

Use of vitamin D drops leading to kidney failure in a 54-year-old man.

Auguste BL, Avila-Casado C, Bargman JM.

CMAJ. 2019 Apr 8;191(14):E390-E394. doi: 10.1503/cmaj.180465. No abstract available.

PMID:
30962197
3.

Supporting the Establishment of New Home Dialysis Programs Through the Explore Home Dialysis Program.

Morita PP, Huynh K, Zakir A, Cafazzo JA, McQuillan RF, Bargman JM, Chan CTM.

Kidney Int Rep. 2018 Oct 29;4(2):293-300. doi: 10.1016/j.ekir.2018.10.019. eCollection 2019 Feb.

4.

Incremental peritoneal dialysis: New ideas about an old approach.

Auguste BL, Bargman JM.

Semin Dial. 2018 Sep;31(5):445-448. doi: 10.1111/sdi.12712. Epub 2018 May 28.

PMID:
29806970
5.

Antimalarial Drugs for the Prevention of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: The Importance of Controlling Chronic Inflammation?

Rodrigues JC, Bargman JM.

Clin J Am Soc Nephrol. 2018 May 7;13(5):679-680. doi: 10.2215/CJN.03300318. Epub 2018 Apr 16. No abstract available.

6.

Should we look beyond Kt/V urea in assessing dialysis adequacy?

Jones CB, Bargman JM.

Semin Dial. 2018 Jul;31(4):420-429. doi: 10.1111/sdi.12684. Epub 2018 Mar 23. Review.

PMID:
29573025
7.

Visions in a Crystal Ball: The Future of Peritoneal Dialysis.

Bargman JM, Girsberger M.

Blood Purif. 2018;45(1-3):218-223. doi: 10.1159/000485158. Epub 2018 Jan 26. Review.

8.

Increased Serum Lactate in Peritoneal Dialysis Patients Presenting with Intercurrent Illness.

Trinh E, Saiprasertkit N, Bargman JM.

Perit Dial Int. 2018 Sep-Oct;38(5):363-365. doi: 10.3747/pdi.2017.00169. Epub 2018 Jan 31.

PMID:
29386309
9.

Peritoneal Dialysis in Orthotopic Liver Transplantation Recipients.

Saiprasertkit N, Nihei CH, Bargman JM.

Perit Dial Int. 2018 Jan-Feb;38(1):44-48. doi: 10.3747/pdi.2017.00134. Epub 2017 Nov 21.

PMID:
29162680
10.

Klebsiella pneumoniae Renal Abscess and Peritonitis in a Peritoneal Dialysis Patient: A Novel Route of Infection.

Dhruve MJ, Bargman JM.

Perit Dial Int. 2017 Nov-Dec;37(6):654-656. doi: 10.3747/pdi.2017.00094.

PMID:
29123004
11.

Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment Outcomes.

Whitty R, Bargman JM, Kiss A, Dresser L, Lui P.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2016-2022. doi: 10.2215/CJN.00630117. Epub 2017 Nov 7.

12.

Can we manage lupus nephritis without chronic corticosteroids administration?

Lightstone L, Doria A, Wilson H, Ward FL, Larosa M, Bargman JM.

Autoimmun Rev. 2018 Jan;17(1):4-10. doi: 10.1016/j.autrev.2017.11.002. Epub 2017 Nov 3. Review.

13.

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review.

Ramirez MEG, Bargman JM.

J Adv Res. 2017 Sep;8(5):551-554. doi: 10.1016/j.jare.2017.04.006. Epub 2017 May 2. Review.

14.

The Interaction of Dialysis Prescription and Residual Kidney Function: Yet Another Layer of Complexity.

Bargman JM, Jones CB.

Am J Kidney Dis. 2017 Apr;69(4):489-491. doi: 10.1053/j.ajkd.2017.01.001. No abstract available.

PMID:
28340849
15.

The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT; American Society of Nephrology Dialysis Advisory Group.

Clin J Am Soc Nephrol. 2017 May 8;12(5):839-847. doi: 10.2215/CJN.08460816. Epub 2017 Mar 17. Review.

16.

Ethical issues in dialysis therapy.

Jha V, Martin DE, Bargman JM, Davies S, Feehally J, Finkelstein F, Harris D, Misra M, Remuzzi G, Levin A; International Society of Nephrology Ethical Dialysis Task Force.

Lancet. 2017 May 6;389(10081):1851-1856. doi: 10.1016/S0140-6736(16)32408-4. Epub 2017 Feb 24.

PMID:
28238456
17.

Dialysis Modality and Readmission Following Hospital Discharge: A Population-Based Cohort Study.

Perl J, McArthur E, Bell C, Garg AX, Bargman JM, Chan CT, Harel S, Li L, Jain AK, Nash DM, Harel Z.

Am J Kidney Dis. 2017 Jul;70(1):11-20. doi: 10.1053/j.ajkd.2016.10.020. Epub 2017 Jan 6.

PMID:
28069285
18.

Antibiotic Prophylaxis in Peritoneal Dialysis Patients.

Dhruve MJ, Bargman JM.

Adv Perit Dial. 2017 Jan;33(2017):55-58.

PMID:
29668433
19.

Renal Tubular Toxicity Associated With Rosuvastatin Therapy.

Ward FL, John R, Bargman JM, McQuillan RF.

Am J Kidney Dis. 2017 Mar;69(3):473-476. doi: 10.1053/j.ajkd.2016.08.037. Epub 2016 Nov 14.

PMID:
27856086
20.

Myths in peritoneal dialysis.

Lee MB, Bargman JM.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):602-608. Review.

PMID:
27584930

Supplemental Content

Loading ...
Support Center